Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€274.70

€274.70

0.220%
0.6
0.220%
€318.32
 
12:17 / Tradegate WKN: 932242 / Symbol: ICLR / Name: ICON / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Icon plc Stock

The Icon plc stock is trending slightly upwards today, with an increase of €0.60 (0.220%) compared to yesterday's price.
With 15 Buy predictions and not the single Sell prediction the community is currently very high on Icon plc.
With a target price of 318 € there is a slightly positive potential of 15.76% for Icon plc compared to the current price of 274.7 €.

Pros and Cons of Icon plc in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Icon plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Icon plc 0.220% -5.743% -10.454% 40.026% 6.035% - -
Alkermes plc -2.630% -5.932% -11.905% -17.164% -11.200% 35.366% -25.000%
Ironwood Pharmaceuticals -0.670% -1.342% -6.369% -28.641% -29.327% -17.416% -36.856%
Novocure Ltd -1.720% -14.085% -11.150% -80.505% -20.736% -92.957% -

Comments

Prediction Buy
Perf. (%) -4.98%
Target price 333.221
Change
Ends at 04.04.25

ICON Public Limited (NASDAQ: ICLR) had its price target raised by analysts at Robert W. Baird from $345.00 to $362.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -5.99%
Target price 318.320
Change
Ends at 04.04.25

ICON Public Limited (NASDAQ: ICLR) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $346.00 price target on the stock.
Ratings data for ICLR provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -5.44%
Target price 323.365
Change
Ends at 23.02.25

ICON Public Limited (NASDAQ: ICLR) had its price target raised by analysts at Evercore ISI from $325.00 to $350.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Show more

News

ICON Announces CFO Transition: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Announces CFO Transition


ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in

ICON plc Schedules First Quarter 2024 Earnings Conference Call: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON plc Schedules First Quarter 2024 Earnings Conference Call


ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2024 after the

ICON plc to Present at Upcoming Investor Conferences: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON plc to Present at Upcoming Investor Conferences


ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the TD Cowen